MARKET

PODD

PODD

Insulet Corp
NASDAQ
284.23
+0.78
+0.28%
After Hours: 284.50 +0.27 +0.10% 17:30 07/18 EDT
OPEN
285.52
PREV CLOSE
283.45
HIGH
286.48
LOW
283.45
VOLUME
349.14K
TURNOVER
--
52 WEEK HIGH
329.33
52 WEEK LOW
173.00
MARKET CAP
20.00B
P/E (TTM)
51.15
1D
5D
1M
3M
1Y
5Y
1D
$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today
Benzinga · 2d ago
RBC Capital Remains a Buy on Insulet (PODD)
TipRanks · 3d ago
Analysts’ Top Healthcare Picks: Insulet (PODD), OrthoPediatrics (KIDS)
TipRanks · 5d ago
Weekly Report: what happened at PODD last week (0707-0711)?
Weekly Report · 5d ago
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?
NASDAQ · 07/09 16:10
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
Simply Wall St · 07/08 16:07
Insulet not impacted by competitive bidding proposal, says BofA
TipRanks · 07/08 12:15
Press Release: Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
Dow Jones · 07/08 10:02
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.